Epic Research Update : Sun Pharmaceutical Industries

Sun Pharmaceutical Industries has received National Stock Exchange’s (NSE) approval to merge ‘specified therapeutic and investment’ business of its subsidiary into itself. As per norms, companies seeking to execute merger or de-merger strategies need to obtain a ‘no-objection certificate’ from stock exchanges.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips